News

Dr. Sallie Permar and other medical experts discuss the dangers of vaccine decline in the U.S., and she notes that kids would be particularly susceptible. Read full article here!

Dr. Sallie Permar explains how H.I.V. medications work and the risk of losing the ability to make an effective vaccine due to drug resistance, if the ban of H.I.V medicines and medical services were to continue. Read The New York Times article here

The Center for Sleep Medicine in Upper East Side Manhattan practice will be relocating from 425 East 61st Street to 525 East 68th Street, 15 Floor of F Building effective February 24, 2025. Our patients will still receive the same all-encompassing care and services as a result of this change. Learn more about the center by clicking here!

The WCM Pediatrics State of the Department Address, delivered by Dr. Sallie Permar, highlighted the department's achievements, innovations, and future goals. Dr. Permar emphasized advancements in pediatric research, clinical care, and education, alongside a commitment to fostering equity and community engagement. The address served as an inspiring call to action for continued excellence in improving children's health.

 Watch full video here!

In this episode of The Incubator Podcast, hosts Ben and Daphna welcome Dr. Cami Martin, a renowned expert in neonatal nutrition. Dr. Martin shares her insights on the evolving landscape of neonatal nutritional care, highlighting the critical role of early nutrition in shaping long-term outcomes for preterm infants. With a wealth of experience in clinical research and bedside practice, Dr. Martin delves into the latest evidence-based strategies to optimize growth and development in the NICU, addressing key challenges faced by neonatal care teams.

Throughout the conversation, Dr. Martin discusses practical approaches to individualized nutrition plans, the importance of fortification strategies, and the potential of emerging innovations in the field. She also provides valuable guidance on how clinicians can implement best practices to support the unique nutritional needs of vulnerable newborns.

Whether you’re a seasoned neonatal professional or new to the field, this episode offers invaluable perspectives on advancing neonatal care through tailored nutritional interventions. Tune in to gain practical takeaways and explore the future of neonatal nutrition with one of the leading voices in the field.

Dr. Michelle Loy, an integrative health specialist discusses the differences between whole, processed, and ultraprocessed foods, their potential health impacts, and practical tips for incorporating more whole foods into your diet on Health Matters. She discusses the health risks associated with ultraprocessed foods, such as increased risks of cancer, cardiovascular disease, diabetes, and mental health issues. Dr. Loy provides practical tips for identifying ultraprocessed foods in grocery stores and offers budget-friendly strategies for incorporating more whole foods into diets, such as meal prepping, using frozen vegetables, and making homemade sauces. Listen here!

The Departments of Pediatrics and Neurology are pleased to announce the recent appointment of Dr. Daniel Lowenstein as Assistant Professor in the Division of Pediatric Neurology.

After receiving his undergraduate degree in Neuroscience and Biology at Brandeis University, where he graduated cum laude as a six-time dean’s list awardee, Dr. Lowenstein completed medical school at Tel Aviv University as part of the New York State/American Program in Israel.

He completed his residency in both pediatrics and child neurology at Children’s Hospital of Pittsburgh and the University of Pittsburgh, followed by an epilepsy fellowship at Johns Hopkins Medical Center in Baltimore. He then joined the faculty at Columbia University Irving Medical Center as Assistant Professor of Neurology. During his time there he served as program director of the adult and pediatric epilepsy fellowship. In addition to his interest in medical education, he is passionate about quality and patient safety. During his time at Columbia, he served on both the quality assurance committees for the department of neurology and pediatrics. In addition, he was a founding member of the Diversity Equity and Inclusion Committee for the Department of Neurology.

The Department of Pediatrics is pleased to announce the appointment of Dr. Lisa Giulino-Roth to Professor of Pediatrics in Medicine, and Professor of Pathology and Laboratory Medicine in the Division of Pediatric Hematology/Oncology, effective December 1, 2024.

Dr. Roth obtained her medical degree at New York University School of Medicine in 2005. She completed residency training in Pediatrics at Weill Cornell Medicine NewYork-Presbyterian, followed by a fellowship in Pediatric Hematology and Oncology in the joint Weill Cornell Medicine Memorial Sloan Kettering Cancer Center program, followed by an additional year, continuing her research in the laboratory of Dr. Ethel Cesarman, tenured Professor of Pathology. Dr. Roth joined Weill Cornell Medicine (WCM) as Assistant Professor in 2012 and was promoted to Associate Professor of Pediatrics in 2019.

She is a physician-scientist with internationally recognized expertise in B-cell lymphoma. Her basic research work has identified targetable genomic changes in lymphoma. She has also done mechanistic work on the role of EZH2 inhibition in tumorigenesis, and on mechanisms of latency in EBV-positive lymphomas. For each of these areas, she has published her findings in high-impact specialty hematology and oncology journals as the corresponding lead or senior author. In addition, Dr. Roth has conducted several large-scale clinical trials in lymphoma in both children and adults.

Increasing the levels of chemicals naturally produced in the body called endocannabinoids may thwart the highly addictive nature of opioids such as morphine and oxycodone while maintaining the drugs’ ability to relieve pain, according to Weill Cornell Medicine investigators working with researchers from The Center for Youth Mental Health at NewYork-Presbyterian. Endocannabinoids bind to cannabinoid receptors throughout the body that regulate activities, such as learning and memory, emotions, sleep, immune response and appetite.

Opioids prescribed to control pain can become addictive because they not only dull pain, but also produce a sense of euphoria. The preclinical study, published Nov. 29 in Science Advances, may lead to a new type of therapeutic that could be taken with an opioid regimen to only reduce the rewarding aspect of opioids.

Specially packaged DNA secreted by tumor cells can trigger an immune response that inhibits the metastatic spread of the tumor to the liver, according to a study led by researchers at Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center and Korea’s Yonsei University. The discovery improves the scientific understanding of cancer progression and anticancer immunity, and could yield new clinical tools for assessing and reducing metastasis risk.

In the study, reported Dec. 3 in Nature Cancer, the researchers examined cancer cells’ secretion of short stretches of DNA packaged on tiny capsules called extracellular vesicles (EVs). All cells use EVs to secrete proteins, DNA and other molecules, and tumor cells are particularly active EV secreters. The biological functions of these EV-packaged molecules are still being explored, but in this case, the researchers discovered that in various cancer types, EV-DNA secreted by tumor cells works as a “danger” signal that activates an anti-tumor response in the liver, reducing the risk of liver metastasis.

Pediatrics Weill Cornell Medicine Appointments & Referrals: (646) 962-KIDS (646) 962-5437 Chair's Office: Weill Cornell Medicine 525 E 68th St.
Box 225
New York, NY 10065 (646) 962-5437